Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bladder Cancer

Free Subscription Articles published in BJU Int Retrieve available abstracts of 180 articles: HTML format Text format

Single Articles

January 2012
1. SHEN P , Yang J, Wei W, Li Y, et al
   Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
   BJU Int. 2012 Jan 31. doi: 10.1111/j.1464-410X.2011.10892.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. KOGA F , Fujii Y, Masuda H, Numao N, et al
   Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
   BJU Int. 2012 Jan 30. doi: 10.1111/j.1464-410X.2011.10874.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GAKIS G , Schwentner C, Todenhoefer T, Stenzl A, et al
   Current status of molecular markers for prognostication and outcome in invasive bladder cancer.
   BJU Int. 2012 Jan 11. doi: 10.1111/j.1464-410X.2011.10839.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. CANDA AE , Atmaca AF, Altinova S, Akbulut Z, et al
   Robot-assisted nerve-sparing radical cystectomy with bilateral extended pelvic lymph node dissection (PLND) and intracorporeal urinary diversion for bladder cancer: initial experience in 27 cases.
   BJU Int. 2011 Dec 16. doi: 10.1111/j.1464-410X.2011.10794.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. FEYISETAN O , Tracey C, Hellawell GO
   Probiotics, dendritic cells and bladder cancer.
   BJU Int. 2011 Dec 16. doi: 10.1111/j.1464-410X.2011.10749.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. CHOUDHURY SM , Mahesan NM, Elhage O, Khan MS, et al
   Oncological outcomes of robot-assisted radical cystectomy.
   BJU Int. 2011;108:1679-80.
   PubMed     Text format     Related articles   
   
   
   
   
7. YATES DR , Vaessen C, Roupret M
   From Leonardo to da Vinci: the history of robot-assisted surgery in urology.
   BJU Int. 2011;108:1708-13.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. ISFOSS BL
   The sensitivity of fluorescent-light cystoscopy for the detection of carcinoma in situ (CIS) of the bladder: a meta-analysis with comments on gold standard.
   BJU Int. 2011;108:1703-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. GAKIS G , Todenhofer T, Renninger M, Schilling D, et al
   Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
   BJU Int. 2011;108:1800-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. LEE R , Ng CK, Shariat SF, Borkina A, et al
    The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy.
    BJU Int. 2011;108:1886-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
11. BLICK CG , Nazir SA, Mallett S, Turney BW, et al
    Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    BJU Int. 2011 Nov 28. doi: 10.1111/j.1464-410X.2011.10664.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. CHOUDHURY A , Cowan R
    Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
    BJU Int. 2011;108:E313.
    PubMed     Text format     Related articles   
    
    
    
    
13. MARIAPPAN P , Finney SM, Head E, Somani BK, et al
    Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation acro
    BJU Int. 2011 Nov 1. doi: 10.1111/j.1464-410X.2011.10571.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. MUKHTAR S , Perry MJ
    Future prospects for bladder cancer biomarkers.
    BJU Int. 2011;108:1541-3.
    PubMed     Text format     Related articles   
    
    
    
    
15. OOI WL , Lee F, Wallace DM, Hayne D, et al
    'One stop' haematuria clinic in Fremantle Hospital, Western Australia: a report of the first 500 patients.
    BJU Int. 2011;108 Suppl 2:62-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. LOSCO G , Antoniou S, Mark S
    Male flexible cystoscopy: does waiting after insertion of topical anaesthetic lubricant improve patient comfort?
    BJU Int. 2011;108 Suppl 2:42-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. ZOU X , Zhang G, Wang X, Yuan Y, et al
    A one-port pneumovesicum method in en bloc laparoscopic nephroureterectomy with bladder cuff resection is feasible and safe for upper tract transitional cell carcinoma.
    BJU Int. 2011;108:1497-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. HSIEH JT , Zhou J, Gore C, Zimmern P, et al
    R11, a novel cell-permeable peptide, as an intravesical delivery vehicle.
    BJU Int. 2011;108:1666-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. MIYAZAKI J , Kawai K, Kojima T, Oikawa T, et al
    The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guein can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands
    BJU Int. 2011;108:1520-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
20. VAN RHIJN BW
    Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.
    BJU Int. 2011;108:1123-4.
    PubMed     Text format     Related articles   
    
    
    
    
21. BAZARBASHI S , Soudy H, Abdelsalam M, Al-Jubran A, et al
    Co-administration of intravesical bacillus Calmette-Guerin and interferon alpha-2B as first line in treating superficial transitional cell carcinoma of the urinary bladder.
    BJU Int. 2011;108:1115-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. GILLION N , Xylinas E, Durand X, Ploussard G, et al
    Mid-term oncological control after laparoscopic radical cystectomy in men: a single-centre experience.
    BJU Int. 2011;108:1180-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. BARBIERE JM , Saeb-Parsy K, Greenberg DC, Wright KA, et al
    Trends in the use of radiotherapy and radical surgery for patients with bladder urothelial cell carcinoma in East Anglia, 1995-2006.
    BJU Int. 2011;108:1106-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. JENSEN JB , Pedersen KV, Olsen KO, Bisgaard UF, et al
    Mini-laparotomy approach to radical cystectomy.
    BJU Int. 2011;108:1125-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ELSHAL AM , Barakat TS, Mosbah A, Abdel-Latif M, et al
    Complications of radical cysto-urethrectomy using modified Clavien grading system: prepubic versus perineal urethrectomy.
    BJU Int. 2011;108:1297-300.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. KHOCHIKAR M
    Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival.
    BJU Int. 2011;108.
    PubMed     Text format     Related articles   
    
    
    
    
27. MAY M , Bastian PJ, Burger M, Bolenz C, et al
    Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder.
    BJU Int. 2011;108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. AHARONY S , Baniel J, Yossepowitch O
    Clinically unconfirmed positive urinary cytology: diagnostic implications and oncological outcomes.
    BJU Int. 2011;108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. HERMANN GG , Mogensen K, Carlsson S, Marcussen N, et al
    Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
    BJU Int. 2011;108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. JAGER W , Thomas C, Haag S, Hampel C, et al
    Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival.
    BJU Int. 2011;108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
31. SCOSYREV E , Messing EM
    Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
    BJU Int. 2011;108:700.
    PubMed     Text format     Related articles   
    
    
    
    
32. BALAR AV , Milowsky MI
    Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
    BJU Int. 2011;108:699.
    PubMed     Text format     Related articles   
    
    
    
    
33. MAYER EK , Bottle A, Aylin P, Darzi AW, et al
    What is the role of risk-adjusted funnel plots in the analysis of radical cystectomy volume-outcome relationships?
    BJU Int. 2011;108:844-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. KURAMOTO T , Fujii R, Nagai H, Belladonna ML, et al
    IL-23 gene therapy for mouse bladder tumour cell lines.
    BJU Int. 2011;108:914-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. HAYN MH , Hellenthal NJ, Seixas-Mikelus SA, Mansour AM, et al
    Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases.
    BJU Int. 2011;108:882-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. MEIJER RP , van Onna IE, Kok ET, Bosch R, et al
    The risk profiles of three clinical types of carcinoma in situ of the bladder.
    BJU Int. 2011;108:839-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. LEE R , Chughtai B, Herman M, Shariat SF, et al
    Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC.
    BJU Int. 2011;108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. SMITH AB , Raynor MC, Pruthi RS
    Peri- and postoperative outcomes of robot-assisted radical cystectomy (RARC).
    BJU Int. 2011;108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. HOSSEINI A , Adding C, Nilsson A, Jonsson MN, et al
    Robotic cystectomy: surgical technique.
    BJU Int. 2011;108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. MESSER J , Shariat SF, Brien JC, Herman MP, et al
    Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
    BJU Int. 2011;108:701-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. NIELSEN JS , Rode F, Rahbek M, Andersson KE, et al
    Effect of the SK/IK channel modulator 4,5-dichloro-1,3-diethyl-1,3-dihydro-benzoimidazol-2-one (NS4591) on contractile force in rat, pig and human detrusor smooth muscle.
    BJU Int. 2011;108:771-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
42. ABDOLLAH F , Sun M, Schmitges J, Djahangirian O, et al
    Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
    BJU Int. 2011 Aug 24. doi: 10.1111/j.1464-410X.2011.10482.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. SEGAL R , Yafi FA, Brimo F, Tanguay S, et al
    Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?
    BJU Int. 2011 Aug 24. doi: 10.1111/j.1464-410X.2011.10462.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. SCOSYREV E , Golijanin D, Wu G, Messing E, et al
    The burden of bladder cancer in men and women: analysis of the years of life lost.
    BJU Int. 2011 Aug 23. doi: 10.1111/j.1464-410X.2011.10318.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ROELANTS M , Huygens A, Crnolatac I, Van Cleynenbreugel B, et al
    Evans blue as a selective dye marker for white-light diagnosis of non-muscle-invasive bladder cancer: an in vitro study.
    BJU Int. 2011 Aug 19. doi: 10.1111/j.1464-410X.2011.10465.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. KOGA F , Kihara K, Yoshida S, Yokoyama M, et al
    Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
    BJU Int. 2011 Aug 19. doi: 10.1111/j.1464-410X.2011.10425.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. BARBIERI CE , Cha EK, Chromecki TF, Dunning A, et al
    Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
    BJU Int. 2011 Aug 18. doi: 10.1111/j.1464-410X.2011.010419.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. BOSTROM PJ , Alkhateeb S, Trottier G, Athanasopoulos PZ, et al
    Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer.
    BJU Int. 2011 Aug 18. doi: 10.1111/j.1464-410X.2011.10371.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. MITRA AP , Quinn DI, Dorff TB, Skinner EC, et al
    Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.
    BJU Int. 2011 Aug 4. doi: 10.1111/j.1464-410X.2011.10455.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. WATTS KL , Ristau BT, Yamase HT, Taylor Iii JA, et al
    Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods?
    BJU Int. 2011;108:484-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. LAMM D
    Editorial comment: Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder.
    BJU Int. 2011;108:530.
    PubMed     Text format     Related articles   
    
    
    
    
52. HERR HW
    Percivall Pott, the environment and cancer.
    BJU Int. 2011;108:479-81.
    PubMed     Text format     Related articles   
    
    
    
    
53. KARAM JA
    Editorial comment: Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.
    BJU Int. 2011;108:537-8.
    PubMed     Text format     Related articles   
    
    
    
    
54. NEUZILLET Y , Yonneau L, Lebret T, Herve JM, et al
    The Z-shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients.
    BJU Int. 2011;108:596-602.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. GUPTA NP , Saini AK, Dogra PN, Seth A, et al
    Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience.
    BJU Int. 2011;108:553-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. AZIZ A , Lessard A, Moore K, Hovington H, et al
    Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.
    BJU Int. 2011;108:531-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. SFAKIANOS JP , Shariat SF, Favaretto RL, Rioja J, et al
    Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder.
    BJU Int. 2011;108:526-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
58. ZUIVERLOON TC , Beukers W, van der Keur KA, Munoz JR, et al
    A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
    BJU Int. 2011 Jul 14. doi: 10.1111/j.1464-410X.2011.10428.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. TAYLOR JM , Feifer A, Savage CJ, Maschino AC, et al
    Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.
    BJU Int. 2011 Jul 1. doi: 10.1111/j.1464-410X.2011.10391.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. SHAO P , Meng X, Li J, Lv Q, et al
    Laparoscopic extended pelvic lymph node dissection during radical cystectomy: technique and clinical outcomes.
    BJU Int. 2011;108:124-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. GILLITZER R , Farasaty-Ghazwiny M, Fritsch J, Schede J, et al
    Extraperitoneal ileal conduit.
    BJU Int. 2011;108:298-301.
    PubMed     Text format     Related articles   
    
    
    
    
62. BRAUSI M
    Radical cystectomy for BCG failure: has the timing improved in recent years?
    BJU Int. 2011;108:186.
    PubMed     Text format     Related articles   
    
    
    
    
63. SHELLEY MD , Cleves A, Wilt TJ, Mason MD, et al
    Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.
    BJU Int. 2011;108:168-79.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. SOLOWAY MS , Hepps D, Katkoori D, Ayyathurai R, et al
    Radical cystectomy for BCG failure: has the timing improved in recent years?
    BJU Int. 2011;108:182-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. LEVIDOU G , Gakiopoulou H, Kavantzas N, Saetta AA, et al
    Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma.
    BJU Int. 2011;108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
66. GEAVLETE B , Multescu R, Georgescu D, Jecu M, et al
    Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
    BJU Int. 2011 Jun 28. doi: 10.1111/j.1464-410X.2011.10374.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. BIRNIE A , Blick C, Fawcett D
    Long-term follow-up of t1 high-grade bladder cancer after intravesical bacille calmette-guerin treatment.
    BJU Int. 2011;107:2002.
    PubMed     Text format     Related articles   
    
    
    
    
68. OZCAN MF , Dizdar O, Canda AE, Balbay MD, et al
    Regional lymph node status in patients with bladder cancer found to be pathological stage t0 at radical cystectomy following systemic chemotherapy.
    BJU Int. 2011;107:2002-3.
    PubMed     Text format     Related articles   
    
    
    
    
69. ZHOU M , He L, Zu X, Zhang H, et al
    Lymphatic vessel density as a predictor of lymph node metastasis and its relationship with prognosis in urothelial carcinoma of the bladder.
    BJU Int. 2011;107:1930-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. RIOJA J , Bandres E, Rosell Costa D, Rincon A, et al
    Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma.
    BJU Int. 2011;107:1833-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
71. SCHNEIDER AC , Heukamp LC, Rogenhofer S, Fechner G, et al
    Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer.
    BJU Int. 2011 May 31. doi: 10.1111/j.1464-410X.2011.10203.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. ZHANG Y , Zhu C, Curado MP, Zheng T, et al
    Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease.
    BJU Int. 2011 May 18. doi: 10.1111/j.1464-410X.2011.10283.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. NEULANDER EZ , Kaneti J
    Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (nmibc).
    BJU Int. 2011;107:1685.
    PubMed     Text format     Related articles   
    
    
    
    
74. MALMSTROM PU
    Bladder tumours: time for a paradigm shift?
    BJU Int. 2011;107:1543-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. SAKANO S , Matsuyama H, Takai K, Yoshihiro S, et al
    Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines.
    BJU Int. 2011;107:1598-604.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
76. FITZPATRICK JM , Bellmunt J, Dreicer R, Fleshner NE, et al
    Maximizing outcomes in genitourinary cancers across the treatment continuum.
    BJU Int. 2011;107 Suppl 2:1-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. GOLAN S , Baniel J, Lask D, Livne PM, et al
    Transurethral resection of bladder tumour complicated by perforation requiring open surgical repair - clinical characteristics and oncological outcomes.
    BJU Int. 2011;107:1065-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. BROWN AL , Cohen RJ
    Inverted papilloma of the urinary tract.
    BJU Int. 2011;107 Suppl 3:24-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
79. KAMAT AM , Karam JA, Grossman HB, Kader AK, et al
    Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.
    BJU Int. 2011 Mar 22. doi: 10.1111/j.1464-410X.2010.10026.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. TICKOO SK , Milowsky MI, Dhar N, Dudas ME, et al
    Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications.
    BJU Int. 2011;107:844-9.
    PubMed     Text format     Related articles   
    
    
    
    
81. GAKIS G , Schilling D, Renninger M, Seibold J, et al
    Comparison of the new American Joint Committee on Cancer substratification in node-negative pT2 urothelial carcinoma of the bladder: analysis of patient outcomes in a contemporary series.
    BJU Int. 2011;107:919-23.
    PubMed     Text format     Related articles   
    
    
    
    
82. SVATEK RS , Shariat SF, Novara G, Skinner EC, et al
    Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort.
    BJU Int. 2011;107:898-904.
    PubMed     Text format     Related articles   
    
    
    
    
83. LIBERMAN D , Alasker A, Sun M, Ismail S, et al
    Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.
    BJU Int. 2011;107:905-11.
    PubMed     Text format     Related articles   
    
    
    
    
84. GHADJAR P , Burkhard FC, Gautschi O, Thalmann GN, et al
    Induction chemotherapy for unresectable urothelial carcinoma of the bladder.
    BJU Int. 2011;107:894-7.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
85. KAAG MG , Milowsky MI, Dalbagni G, Thompson RH, et al
    Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy.
    BJU Int. 2011 Feb 14. doi: 10.1111/j.1464-410X.2010.09981.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. FEDELI U , Novara G, Galassi C, Ficarra V, et al
    Population-based analyses of radical cystectomy and urinary diversion for bladder cancer in northern Italy.
    BJU Int. 2011 Feb 14. doi: 10.1111/j.1464-410X.2011.10095.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. KAKIASHVILI DM , van Rhijn BW, Trottier G, Jewett MA, et al
    Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guerin treatment.
    BJU Int. 2011;107:540-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. WIESNER C , Jager W, Salzer A, Biesterfeld S, et al
    Confocal laser endomicroscopy for the diagnosis of urothelial bladder neoplasia: a technology of the future?
    BJU Int. 2011;107:399-403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. HERR HW , Donat SM
    Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy.
    BJU Int. 2011;107:396-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. HODGES KB , Lopez-Beltran A, Maclennan GT, Montironi R, et al
    Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management.
    BJU Int. 2011;107:532-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. KAUFFMAN EC , Ng CK, Lee MM, Otto BJ, et al
    Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy.
    BJU Int. 2011;107:628-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. KENNEY PA , Wszolek MF, Rieger-Christ KM, Neto BS, et al
    Novel ZEB1 expression in bladder tumorigenesis.
    BJU Int. 2011;107:656-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. BALTACI S , Adsan O, Ugurlu O, Aslan G, et al
    Reliability of frozen section examination of obturator lymph nodes and impact on lymph node dissection borders during radical cystectomy: results of a prospective multicentre study by the Turkish Society of Urooncology.
    BJU Int. 2011;107:547-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. HELLENTHAL NJ , Hussain A, Andrews PE, Carpentier P, et al
    Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
    BJU Int. 2011;107:642-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
95. WINERDAL ME , Marits P, Winerdal M, Hasan M, et al
    FOXP3 and survival in urinary bladder cancer.
    BJU Int. 2011 Jan 18. doi: 10.1111/j.1464-410X.2010.10020.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. PESCH B , Nasterlack M, Eberle F, Bonberg N, et al
    The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
    BJU Int. 2011 Jan 11. doi: 10.1111/j.1464-410X.2010.09971.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. SALEM S , Mitchell RE, El-Alim El-Dorey A, Smith JA, et al
    Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt.
    BJU Int. 2011;107:206-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. RESNICK MJ , Bergey M, Magerfleisch L, Tomaszewski JE, et al
    Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens.
    BJU Int. 2011;107:46-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. CANTER D , Long C, Kutikov A, Plimack E, et al
    Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy.
    BJU Int. 2011;107:58-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. PARADA B , Reis F, Figueiredo A, Nunes P, et al
     Inhibition of bladder tumour growth by sirolimus in an experimental carcinogenesis model.
     BJU Int. 2011;107:135-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     December 2010
101. BADALATO G , Patel T, Hruby G, McKiernan J, et al
     Does the presence of muscularis propria on transurethral resection of bladder tumour specimens affect the rate of upstaging in cT1 bladder cancer?
     BJU Int. 2010 Dec 22. doi: 10.1111/j.1464-410X.2010.09893.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. HINOTSU S , Akaza H, Naito S, Ozono S, et al
     Maintenance therapy with bacillus Calmette-Guerin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer.
     BJU Int. 2010 Dec 22. doi: 10.1111/j.1464-410X.2010.09891.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. MATSUMURA N , Nakamura Y, Kohjimoto Y, Inagaki T, et al
     The prognostic significance of human equilibrative nucleoside transporter 1 expression in patients with metastatic bladder cancer treated with gemcitabine-cisplatin-based combination chemotherapy.
     BJU Int. 2010 Dec 16. doi: 10.1111/j.1464-410X.2010.09932.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
104. STROCK V , Dotevall L, Sandberg T, Gustafsson CK, et al
     Late bacille Calmette-Guerin infection with a large focal urinary bladder ulceration as a complication of bladder cancer treatment.
     BJU Int. 2010 Dec 16. doi: 10.1111/j.1464-410X.2010.09923.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
105. YAFI FA , Aprikian AG, Chin JL, Fradet Y, et al
     Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience.
     BJU Int. 2010 Dec 16. doi: 10.1111/j.1464-410X.2010.09912.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. ROELANTS M , Van Cleynenbreugel B, Van Poppel H, Lerut E, et al
     Use of fluorescein isothiocyanate-human serum albumin for the intravesical photodiagnosis of non-muscle-invasive bladder cancer: an in vitro study using multicellular spheroids composed of normal human urothelial and urothelial cell carcinoma cell lin
     BJU Int. 2010 Dec 13. doi: 10.1111/j.1464-410X.2010.09951.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. THUROFF JW , Riedmiller H, Fisch M, Stein R, et al
     Mainz pouch continent cutaneous diversion.
     BJU Int. 2010;106:1830-54.
     PubMed     Text format     Related articles   
     
     
     
     
108. YOU D , Kim SC, Jeong IG, Hong JH, et al
     Urothelial carcinoma of the bladder with seminal vesicle invasion: prognostic significance.
     BJU Int. 2010;106:1657-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
109. GONTERO P , Cattel L, Paone TC, Milla P, et al
     Pharmacokinetic study to optimize the intravesical administration of gemcitabine.
     BJU Int. 2010;106:1652-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. HARSHMAN LC , Bepler G, Zheng Z, Higgins JP, et al
     Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patients.
     BJU Int. 2010;106:1805-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     November 2010
111. SCOSYREV E , Ely BW, Messing EM, Speights VO, et al
     Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).
     BJU Int. 2010 Nov 24. doi: 10.1111/j.1464-410X.2010.09900.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
112. YOUSSEF R , Kapur P, Kabbani W, Shariat SF, et al
     Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.
     BJU Int. 2010 Nov 24. doi: 10.1111/j.1464-410X.2010.09854.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
113. SONPAVDE G , Khan MM, Svatek RS, Lee R, et al
     Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
     BJU Int. 2010 Nov 19. doi: 10.1111/j.1464-410X.2010.09902.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. SHIOTA M , Yokomizo A, Itsumi M, Uchiumi T, et al
     Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells.
     BJU Int. 2010 Nov 17. doi: 10.1111/j.1464-410X.2010.09810.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. JEONG IG , Ro JY, Kim SC, You D, et al
     Extranodal extension in node-positive bladder cancer: the continuing controversy.
     BJU Int. 2010 Nov 11. doi: 10.1111/j.1464-410X.2010.09823.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
116. LAVERY HJ , Martinez-Suarez HJ, Abaza R
     Robotic extended pelvic lymphadenectomy for bladder cancer with increased nodal yield.
     BJU Int. 2010 Nov 11. doi: 10.1111/j.1464-410X.2010.09789.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
117. MIR C , Shariat SF, Van Der Kwast TH, Ashfaq R, et al
     Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study.
     BJU Int. 2010 Nov 10. doi: 10.1111/j.1464-410X.2010.09834.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
118. MAKHLIN I , Zhang J, Long CJ, Devarajan K, et al
     The mTOR pathway affects proliferation and chemosensitivity of urothelial carcinoma cells and is upregulated in a subset of human bladder cancers.
     BJU Int. 2010 Nov 2. doi: 10.1111/j.1464-410X.2010.09844.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
119. THULIN H , Kreicbergs U, Onelov E, Ahlstrand C, et al
     Defecation disturbances after cystectomy for urinary bladder cancer.
     BJU Int. 2010 Nov 2. doi: 10.1111/j.1464-410X.2010.09815.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. GURU KA , Mansour AM, Nyquist J
     Robot-assisted intracorporeal ileal conduit 'Marionette' technique.
     BJU Int. 2010;106:1404-20.
     PubMed     Text format     Related articles   
     
     
     
     
121. BOLENZ C , Ho R, Nuss GR, Ortiz N, et al
     Management of elderly patients with urothelial carcinoma of the bladder: guideline concordance and predictors of overall survival.
     BJU Int. 2010;106:1324-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
122. PIERAS E , Frontera G, Ruiz X, Vicens A, et al
     Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma.
     BJU Int. 2010;106:1319-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. DALBAGNI G , Kaag M, Cronin A, Vora K, et al
     Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma.
     BJU Int. 2010;106:1502-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
124. SALINAS-SANCHEZ AS , Sanchez-Sanchez F, Donate-Moreno MJ, Rubio-Del-Campo A, et al
     Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
     BJU Int. 2010 Oct 13. doi: 10.1111/j.1464-410X.2010.09683.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. COLOMBO R , Salonia A, Leib Z, Pavone-Macaluso M, et al
     Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC).
     BJU Int. 2010 Oct 4. doi: 10.1111/j.1464-410X.2010.09654.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
126. FROBISHER C , Gurung PM, Leiper A, Reulen RC, et al
     Risk of bladder tumours after childhood cancer: the British Childhood Cancer Survivor Study.
     BJU Int. 2010;106:1060-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. CORNEL EB
     Transurethral resection of bladder tumours.
     BJU Int. 2010;106:1237.
     PubMed     Text format     Related articles   
     
     
     
     
128. BOLENZ C , Shariat SF, Karakiewicz PI, Ashfaq R, et al
     Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder.
     BJU Int. 2010;106:1216-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
129. SZARVAS T , Singer BB, Becker M, Vom Dorp F, et al
     Urinary matrix metalloproteinase-7 level is associated with the presence of metastasis in bladder cancer.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
130. MAAROUF AM , Khalil S, Salem EA, Eladl M, et al
     Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
131. HUDDART RA , Hall E, Lewis R, Birtle A, et al
     Life and death of spare (selective bladder preservation against radical excision): reflections on why the spare trial closed.
     BJU Int. 2010;106:753-5.
     PubMed     Text format     Related articles   
     
     
     
     
132. YATES DR , Catto JW
     Time to change our approach to high-risk nonmuscle-invasive bladder cancer management in the United Kingdom? Observations from the British Association of Urological Surgeons Cancer Registry.
     BJU Int. 2010;106:593-4.
     PubMed     Text format     Related articles   
     
     
     
     
133. LODDE M , Lacombe L, Friede J, Morin F, et al
     Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma.
     BJU Int. 2010;106:658-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. ASHLEY MS , Daneshmand S
     Factors influencing the choice of urinary diversion in patients undergoing radical cystectomy.
     BJU Int. 2010;106:654-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
135. BEHNSAWY HM , Miyake H, Abdalla MA, Sayed MA, et al
     Expression of integrin proteins in non-muscle-invasive bladder cancer: significance of intravesical recurrence after transurethral resection.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
136. VERMA A , Degrado J, Hittelman AB, Wheeler MA, et al
     Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. RINK M , Chun FK, Minner S, Friedrich M, et al
     Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. SHIOTA M , Tsunoda T, Song Y, Yokomizo A, et al
     Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. OTTO W , Denzinger S, Fritsche HM, Burger M, et al
     The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. BOORJIAN SA , Zhu F, Herr HW
     The effect of gender on response to bacillus Calmette-Guerin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder.
     BJU Int. 2010;106:357-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
141. ZAAK D , Burger M, Otto W, Bastian PJ, et al
     Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
     BJU Int. 2010;106:342-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. MIYAKE H , Furukawa J, Muramaki M, Takenaka A, et al
     Orthotopic sigmoid neobladder after radical cystectomy: assessment of complications, functional outcomes and quality of life in 82 Japanese patients.
     BJU Int. 2010;106:412-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. LIGUORI G , Amodeo A, Mucelli FP, Patel H, et al
     Intractable haematuria: long-term results after selective embolization of the internal iliac arteries.
     BJU Int. 2010;106:500-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. ALANEE S , Shukla AR
     Bladder malignancies in children aged <18 years: results from the Surveillance, Epidemiology and End Results database.
     BJU Int. 2010;106:557-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
145. TAYLOR JM , Spiess PE, Kassouf W, Munsell MF, et al
     Management of urethral recurrence after orthotopic urinary diversion.
     BJU Int. 2010;106:56-61.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. HERR H , Donat M, Dalbagni G, Taylor J, et al
     Narrow-band imaging cystoscopy to evaluate bladder tumours--individual surgeon variability.
     BJU Int. 2010;106:53-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
147. WIESNER C , Jager W, Thuroff JW
     Surgery illustrated - surgical atlas.
     BJU Int. 2010;105:1610-21.
     PubMed     Text format     Related articles   
     
     
     
     
148. MARTIN AD , Nunez RN, Pacelli A, Woods ME, et al
     Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 months.
     BJU Int. 2010;105:1706-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
149. KATKOORI D , Samavedi S, Kava B, Soloway MS, et al
     Synchronous panniculectomy with stomal revision for obese patients with stomal stenosis and retraction.
     BJU Int. 2010;105:1586-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     May 2010
150. BLACK PC , Shetty A, Brown GA, Esparza-Coss E, et al
     Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosis.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
151. BRYAN RT , Wallace MA
     Is it time to re-design the haematuria clinic?
     BJU Int. 2010;105:1478-9.
     PubMed     Text format     Related articles   
     
     
     
     
152. SHARIAT SF , Svatek RS, Tilki D, Skinner E, et al
     International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
     BJU Int. 2010;105:1402-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. CHUANG KL , Chuang HC, Ng KF, Chang YH, et al
     Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients.
     BJU Int. 2010;105:1413-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     April 2010
154. VILLARI D , Nesi G, Della Melina A, Palli D, et al
     Radical retropubic prostatectomy for prostate cancer with microscopic bladder neck involvement: survival and prognostic implications.
     BJU Int. 2010;105:946-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     March 2010
155. HERR HW , Al-Ahmadie H, Dalbagni G, Reuter VE, et al
     Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
156. PUPPO P , Conti G, Francesca F, Mandressi A, et al
     New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classification.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
157. TRITSCHLER S , Karl A, Sommer ML, Straub J, et al
     Influence of clinical information on the interpretation of urinary cytology in bladder cancer: how suggestible is a cytologist?
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
158. KU JH , Seo SY, Kwak C, Kim HH, et al
     Cytotoxicity and apoptosis by survivin small interfering RNA in bladder cancer cells.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
159. YATES DR , Roupret M
     Failure of bacille Calmette-Guerin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. MOSTAFID H , Persad R, Kockelbergh R, Fawcett D, et al
     Is it time to re-design the haematuria clinic?
     BJU Int. 2010;105:585-8.
     PubMed     Text format     Related articles   
     
     
     
     
161. PLOUSSARD G , Rotondo S, Salomon L
     The prognostic significance of bladder neck invasion in prostate cancer: is microscopic involvement truly a T4 disease?
     BJU Int. 2010;105:776-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
162. RAY ER , Chatterton K, Khan MS, Chandra A, et al
     Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guerin.
     BJU Int. 2010;105:789-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. KATKOORI D , Samavedi S, Adiyat KT, Soloway MS, et al
     Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?
     BJU Int. 2010;105:795-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. TOLLEFSON MK , Elliott DS, Zincke H, Frank I, et al
     Long-term outcome of ureterosigmoidostomy: an analysis of patients with >10 years of follow-up.
     BJU Int. 2010;105:860-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     February 2010
165. AYRES BE , Crew JP
     Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?
     BJU Int. 2010;105 Suppl 2:14-7.
     PubMed     Text format     Related articles   
     
     
     
     
166. AYRES BE , Griffiths TR, Persad RA
     Is the role of intravesical bacillus Calmette-Guerin in non-muscle-invasive bladder cancer changing?
     BJU Int. 2010;105 Suppl 2:8-13.
     PubMed     Text format     Related articles   
     
     
     
     
167. BUNCE C , Ayres BE, Griffiths TR, Mostafid H, et al
     The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer.
     BJU Int. 2010;105 Suppl 2:2-7.
     PubMed     Text format     Related articles   
     
     
     
     
168. HERR HW
     Narrow-band imaging cystoscopy to evaluate the response to bacille Calmette-Guerin therapy: preliminary results.
     BJU Int. 2010;105:314-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
169. GAKIS G , Schilling D, Bedke J, Sievert KD, et al
     Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery.
     BJU Int. 2010;105:468-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. LIU D , Feng F, Shen Z, Xia W, et al
     Clinical experience in a modified Roux-Y-shaped sigmoid neobladder: assessment of complications and voiding patterns in 43 patients.
     BJU Int. 2010;105:533-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
171. KAUFFMAN EC , Ng CK, Lee MM, Otto BJ, et al
     Critical analysis of complications after robotic-assisted radical cystectomy with identification of preoperative and operative risk factors.
     BJU Int. 2010;105:520-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. SHARIAT SF , Bolenz C, Karakiewicz PI, Fradet Y, et al
     p53 expression in patients with advanced urothelial cancer of the urinary bladder.
     BJU Int. 2010;105:489-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
173. MATSUI Y , Watanabe J, Ding S, Nishizawa K, et al
     Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells through p38 activation.
     BJU Int. 2010;105:558-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     January 2010
174. GRADILONE A , Petracca A, Nicolazzo C, Gianni W, et al
     Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
175. PRUTHI RS , Nielsen M, Heathcote S, Wallen EM, et al
     A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. SERRETTA V , Morgia G, Altieri V, Di Lallo A, et al
     A 1-year maintenance after early adjuvant intravesical chemotherapy has a limited efficacy in preventing recurrence of intermediate risk non-muscle-invasive bladder cancer.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. LOW VJ , Wang D, Abel PD
     Survival of patients with bladder cancer from a UK hospital: a 10-year follow-up study.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. BOLENZ C , Herrmann E, Bastian PJ, Michel MS, et al
     Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
     BJU Int. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. BLANCHET KD
     Redefining personalized medicine in the postgenomic era: developing bladder cancer therapeutics with proteomics.
     BJU Int. 2010;105:i-iii.
     PubMed     Text format     Related articles   
     
     
     
     December 2009
180. TRAVER MA , Vaughan ED, Porter CR
     Radical retropubic cystectomy.
     BJU Int. 2009;104:1800-21.
     PubMed     Text format     Related articles   
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: